The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease

Renal Failure

Volumn 35, Issue 4, 2013, Pages 434-439

  Oguzhan, Nilufer ^a   Cilan, Havva ^a   Sipahioglu, Murat ^a   Unal, Aydin ^a   Kocyigit, Ismail ^a   Kavuncuoglu, Feridun ^a   Arikan, Tamer ^a   Akpek, Mahmut ^b   Elcik, Deniz ^b   Sahin, Omer ^b   Gulme, Ebru ^b   Pala, Cigdem ^b   Tokgoz, Bulent ^a   Utas, Cengiz ^a   Oguzhan, Abdurrahman ^b   Oymak, Oktay ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Angiotensin receptor blockers; Calcium channel blockers; Contrast induced nephropathy

Indexed keywords

AMLODIPINE PLUS VALSARTAN; CREATININE; DIURETIC AGENT; HEMOGLOBIN; IOPROMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM CHLORIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDRATION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEHRAN SCORE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; REPEAT PROCEDURE; RISK ASSESSMENT; SCORING SYSTEM; SMOKING;

AGED; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; CONTRAST MEDIA; CREATININE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; SODIUM CHLORIDE; TETRAZOLES; TREATMENT OUTCOME;

EID: 84876350133     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.766566     Document Type: Article

References (19)

1. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: A prospective study. Am J Med. 1983;74(2):243-248
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930-936
3. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19): 2259-2264
4. Arici M, Usalan C, Altun B, et al. Radiocontrast-induced nephrotoxicity and urinary alpha-glutathione S-transferase levels: Effect of amlodipine administration. Int Urol Nephrol. 2003;35:255-261
5. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephropathy in diabetic patients: A randomised study. Indian Heart J. 1999;51:521-526
6. Simpson DH, Chin CT, Burns PN. Pulse inversion Doppler: A new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46(2):372-382
7. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399
8. Rosenstock JL, Bruno R, Kim JK, et al. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol. 2008;40:749-755
9. Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDMpatients with diabetic nephropathy during the first year of treatment. Diabetes. 1997;46:481-487
10. Velussi M, Brocco E, Frigato F. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes. 1996;45:216-222
11. Zucchelli P, Zuccala A, Borghi M. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int. 1992;42:452-458
12. Toprak O, Cirit M, Bayata S, Yeşil M, Aslan SL. The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography. Anadolu Kardiyol Derg. 2003;3:98-103
13. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13-19
14. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990;150:1237-1242
15. Kohli HS, Bhaskaran MC, Muthukumar T, et al. Treatment related acute renal failure in the elderly: A hospital-based prospective study. Nephrol Dial Transplant. 2000;15:212-217
16. Cirit M, Toprak O, Yesil M, et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract. 2006;104:20-27
17. Bakris GL, Burnett JC Jr. A role for calcium in radiocontrastinduced reductions in renal hemodynamics. Kidney Int. 1985;27:465-468
18. Spångberg-Viklund B, Berglund J, Nikonoff T, Nyberg P, Skau T, Larsson R. Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function? Scand J Urol Nephrol. 1996;30:63-68
19. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005;67(2):706-713